Department of Cardiology, University Hospital Bern, Bern, Switzerland; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Department of Cardiology, University Hospital Bern, Bern, Switzerland.
J Am Coll Cardiol. 2024 Oct 8;84(15):1373-1387. doi: 10.1016/j.jacc.2024.07.018.
The European Society of Cardiology (ESC), the American College of Cardiology, the American Heart Association, and expert consensus documents provide different diagnostic criteria for myocarditis. Their overlap and prognostic value have never been compared.
This study aims to assess and compare the predictive value of ESC criteria for clinically suspected myocarditis, updated Lake-Louise criteria (LLC), American Heart Association criteria for probable acute myocarditis (pAM), and expert consensus criteria for acute myocarditis (AM) and complicated myocarditis (CM).
Patients with a clinical suspicion of myocarditis referred for cardiac magnetic resonance were enrolled at 2 centers. Those with any prior cardiomyopathy were excluded. The association of composite outcome events (heart failure hospitalization, recurrent myocarditis, sustained ventricular tachycardia, or death) with ESC diagnostic criteria, LLC, pAM, AM, and CM were compared.
Among 1,557 consecutive patients referred for cardiac magnetic resonance with possible myocarditis, 1,050 (62.6% male; 48.9 ± 16.8 years of age) were without an alternative diagnosis. Of those, 938 (89.3%) met ESC criteria for clinically suspected myocarditis, 299 (28.5%) LLC, and 356 (33.9%), 216 (20.6%), and 77 (7.3%) pAM, AM, and CM, respectively. Adverse events occurred in 161 patients (15.3%) during a median follow-up of 3.4 years. The highest annualized event rates (6.6%) were observed in patients meeting LLC, whereas negative ESC criteria indicated excellent prognosis (0.7% annualized event rate). Among all myocarditis definitions, ESC criteria and LLC were the strongest multivariable outcome predictors and had independent and incremental prognostic value (HR: 3.87; 95% CI: 1.22-12.2; P = 0.021, and HR: 2.53; 95% CI: 1.83-3.49; P < 0.001, respectively) when adjusted for clinical characteristics.
In a real-world cohort of patients with possible myocarditis, diagnosis was reached in most patients using ESC criteria whereas only approximately one-quarter of patients reached a diagnosis with LLC. The independent prognostic value of ESC-criteria and LLC highlights the complementary role of clinical and CMR-based findings in the diagnosis and risk stratification of myocarditis.
欧洲心脏病学会(ESC)、美国心脏病学会(ACC)、美国心脏协会(AHA)以及专家共识文件提供了不同的心肌炎诊断标准。它们之间的重叠和预后价值从未被比较过。
本研究旨在评估和比较 ESC 标准对临床疑似心肌炎、更新的莱克-路易丝标准(LLC)、AHA 可能急性心肌炎标准(pAM)和急性心肌炎专家共识标准(AM)和复杂心肌炎(CM)的预测价值。
在 2 个中心招募了因临床疑似心肌炎而接受心脏磁共振检查的患者。排除任何先前存在的心肌病患者。比较复合结局事件(心力衰竭住院、复发性心肌炎、持续性室性心动过速或死亡)与 ESC 诊断标准、LLC、pAM、AM 和 CM 的相关性。
在 1557 例因可能心肌炎而接受心脏磁共振检查的连续患者中,1050 例(62.6%为男性;48.9±16.8 岁)无其他诊断。其中,938 例(89.3%)符合 ESC 临床疑似心肌炎标准,299 例符合 LLC,356 例符合 pAM,216 例符合 AM,77 例符合 CM。中位随访 3.4 年后,161 例患者(15.3%)发生不良事件。在 LLC 患者中观察到最高的年化事件发生率(6.6%),而 ESC 阴性标准则预示着良好的预后(年化事件发生率为 0.7%)。在所有心肌炎定义中,ESC 标准和 LLC 是最强的多变量预后预测指标,具有独立和增量的预后价值(HR:3.87;95%CI:1.22-12.2;P=0.021,和 HR:2.53;95%CI:1.83-3.49;P<0.001,分别),当调整临床特征时。
在可能患有心肌炎的真实世界队列中,大多数患者使用 ESC 标准做出诊断,而仅约四分之一的患者符合 LLC 诊断标准。ESC 标准和 LLC 的独立预后价值突出了临床和基于 CMR 的发现在心肌炎诊断和风险分层中的互补作用。